Company profile

Ticker
IBM
Exchange
Website
CEO
Virginia M. Rometty
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
130871985

IBM stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Calendar

30 Oct 19
25 Feb 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 18.03B 19.16B 18.18B 21.76B
Net income 1.67B 2.5B 1.59B 1.95B
Diluted EPS 1.87 2.81 1.78 2.15
Net profit margin 9.27% 13.04% 8.75% 8.97%
Operating income* 1.95B 3.12B 2.09B 4.63B
Net change in cash -35.31B 28.27B 5.76B -184M
Cash on hand 10.09B 45.4B 17.13B 11.38B
Cost of revenue 9.69B 10.15B 10.14B 11.07B
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 79.59B 79.14B 79.92B 81.74B
Net income 8.73B 5.75B 11.87B 13.19B
Diluted EPS 9.52 6.14 12.38 13.42
Net profit margin 10.97% 7.27% 14.86% 16.14%
Operating income* 12.07B 12.02B 12.96B 16.41B
Net change in cash -593M 4.15B 140M -790M
Cash on hand 11.38B 11.97B 7.83B 7.69B
Cost of revenue 42.66B 42.2B 41.4B 41.06B

Financial data from company earnings reports. *Asterisk values are approximate.

56.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1998 1923 +3.9%
Opened positions 224 111 +101.8%
Closed positions 149 97 +53.6%
Increased positions 704 762 -7.6%
Reduced positions 819 753 +8.8%
13F shares
Current Prev Q Change
Total value 801.02B 953.38B -16.0%
Total shares 497.29M 495.29M +0.4%
Total puts 12.74M 12.57M +1.3%
Total calls 8.89M 11.42M -22.2%
Total put/call ratio 1.4 1.1 +30.2%
Largest owners
Shares Value Change
Vanguard 73.44M $9.84B +1.7%
BLK BlackRock 62.13M $8.33B +1.6%
STT State Street 54.49M $7.3B +1.2%
Geode Capital Management 12.84M $1.72B +3.2%
NTRS Northern Trust 11.05M $1.48B -6.0%
BK Bank Of New York Mellon 10.09M $1.35B -18.9%
MS Morgan Stanley 9.76M $1.31B +14.7%
BAC Bank of America 7.63M $1.02B +5.0%
Charles Schwab Investment Management 7.58M $1.02B +1.3%
AMP Ameriprise Financial 6.43M $862.53M -8.6%
Largest transactions
Shares Bought/sold Change
Wellington Management 2.89M -3.09M -51.6%
BK Bank Of New York Mellon 10.09M -2.36M -18.9%
JHG Janus Henderson 2.66M +1.52M +133.2%
GS The Goldman Sachs Group, Inc. 6.21M +1.5M +31.7%
Renaissance Technologies 1.55M +1.44M +1353.9%
BEN Franklin Resources 985.1K -1.4M -58.6%
MS Morgan Stanley 9.76M +1.25M +14.7%
BCS Barclays 3.53M +1.25M +54.4%
Vanguard 73.44M +1.22M +1.7%
Barrow Hanley Mewhinney & Strauss 1.12K -1.02M -99.9%

Financial report summary

?
Competition
IntelLeidosCALSIQuantumSun MicrosystemsOracleQualstarOracle SystemsMicrosoft
Management Discussion
  • In the third quarter, Global Financing total revenue of $645 million declined 11.2 percent compared to the prior year. Internal revenue decreased 10.6 percent, driven by a decrease in internal financing (down 21.7 percent to $86 million) and internal used equipment sales (down 5.2 percent to $216 million). External revenue decreased 11.7 percent (11 percent adjusted for currency), due to a decrease in external financing (down 14.6 percent to $261 million) and external used equipment sales (down 1.0 percent to $81 million).
  • The decrease in total revenue in the first nine months of 2019 compared to the same period of 2018 was due to a decrease in internal revenue of 28.7 percent, driven by a decrease in internal used equipment sales (down 36.0 percent to $593 million) and internal financing (down 7.4 percent to $291 million). External revenue decreased 7.4 percent (5 percent adjusted for currency), driven by a decline in external used equipment sales (down 19.9 percent to $216 million) and external financing (down 3.7 percent to $884 million).
  • The decrease in internal financing revenue in the third quarter and the first nine months of 2019 compared to the same periods in 2018 was primarily due to lower average asset balances, partially offset by higher asset yields. The decrease in external financing revenue in the third quarter and the first nine months of 2019 compared to the same periods in 2018 reflects the company’s wind down of the OEM IT commercial financing operations.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: acquiree, advisory, amortizable, Ansible, assembled, attrition, back, CIS, CISGIL, consumed, consummated, containerizing, cyber, deal, deductible, earned, equivalent, facing, fiscal, forma, holistic, instant, Internet, introduction, larger, leading, lifecycle, McNabb, NaN, native, OpenShift, pro, purport, resource, retention, RHEL, Salesforce, settle, settled, slightly, temporary, thirteen, weaker, week, William, wrongful
Removed: ahead, building, economy, effectively, efficiently, embedding, enable, exit, Factory, hana, improving, intent, iX, leadership, letter, long, Migration, optimizing, returning, seasonal, shifting, suspend, traditional, uniquely, vast

Patents

GRANT
Utility
Surgical skin lesion removal
25 Feb 20
Embodiments include methods, systems, and computer program products for treating skin lesions.
GRANT
Utility
Apparatus for supporting personalized coronary stents
25 Feb 20
A method including generating a 3-D model of an unstenosed geometry of a blood vessel responsive to a 3-D model of an actual geometry of the blood vessel, establishing a parametric description of a stent that is expanded from a collapsed configuration to a final configuration that apposes the unstenosed geometry, developing a design for the stent by varying parameters of the parametric description responsive to a design heuristic that includes risk of stent strut breakage during a plastic deformation between the collapsed configuration and the final configuration, embodying the stent according to the design for the stent, inserting the stent into a blood vessel in its collapsed configuration, maneuvering the stent through the blood vessel to a stenosis, and expanding the stent to its final configuration.
GRANT
Utility
Personalized coronary stent methods
25 Feb 20
A method including generating a 3-D model of an unstenosed geometry of a blood vessel responsive to a 3-D model of an actual geometry of the blood vessel, establishing a parametric description of a stent that is expanded from a collapsed configuration to a final configuration that apposes the unstenosed geometry, developing a design for the stent by varying parameters of the parametric description responsive to a design heuristic that includes risk of stent strut breakage during a plastic deformation between the collapsed configuration and the final configuration, embodying the stent according to the design for the stent, inserting the stent into a blood vessel in its collapsed configuration, maneuvering the stent through the blood vessel to a stenosis, and expanding the stent to its final configuration.
GRANT
Utility
Drying an extreme ultraviolet (EUV) pellicle
25 Feb 20
Systems and methods for rinsing one or more pellicles during fabrication, including immersing and soaking the one or more pellicles in a rinse bath solution for a particular time period, forming a top layer above the rinse bath solution, the top layer having a lower surface tension than the rinse bath, and withdrawing the one or more pellicles through the top layer for drying.
GRANT
Utility
Maintenance of a machine
25 Feb 20
A system for maintaining a machine.